SEC Form 4 · accession 0001628280-26-043007
Pacira BioSciences, Inc. · PCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas G Wiggans
Director
Period of report
Jun 10, 2026
Accepted (ET)
Jun 12, 2026 · 9:07 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001396814
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $23.42 | Jun 10, 2026 | A | 32,675 | A | — | Jun 10, 2036 | Common Stock | 32,675 | 32,675 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable as to one-third of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal monthly installments over the subsequent two years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.